Notice of extraordinary general meeting
Filed with HKEX · Stock code 2500 · · 2 pages · English
Summary by 6ix AI
This filing is a notice for an extraordinary general meeting of Venus Medtech (Hangzhou), Inc.. The meeting will consider a special resolution regarding the approval of a subscription of shares and convertible bonds. Shareholders are entitled to attend and vote, with specific instructions for registration and proxy appointments provided.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Venus Medtech (Hangzhou), Inc. on 6ix
Earlier from Venus Medtech (Hangzhou)
- Proposed subscription of new shares and new convertible bonds under specific mandate and (2) notice of extraordinary general meeting
- Cardiovalve Completes TARGET Study Enrollment for CE Registration Study for Tricuspid Valve Replacement
- Court Sides with Cardiovalve in Edwards patent spat
- Venus Medtech Reports 2024 Annual Results: Profitability Surges with Robust Global Expansion and Innovations
- Venus Medtech Concludes Acquisition of 100% Equity Interest in Cardiovalve
Later from Venus Medtech (Hangzhou)
- Proxy form for use at the EGM
- 2026 Interim report
- Poll results of the extraordinary general meeting
- Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 30 September 2026
- Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 31 October 2026
Follow Venus Medtech (Hangzhou) into a list and get an email when it puts out news.
Follow Venus Medtech (Hangzhou)